Article
[A case of remnant liver metastases after resection of liver metastases from rectal cancer following treatment with 5-FU, L-OHP and CPT-11, with markedly effective treatment by cetuximab plus S-1].
Gan to kagaku ryoho. Cancer & chemotherapy - 1 May 2012
Takeuchi Masaaki, Ogata Yutaka, Ishibashi Nobuya, Uchida Shinji, Murakami Naotaka, Kibe Shirou, Takahashi Kenjirou, Yahara Toshirou, Shirouzu Kazuo
Abstract excerpt
FOLFOX or FOLFIRI are commonly used as first- or second-line chemotherapy for unresectable colorectal cancer or its metastases.Recently, it had become a trend to add bevacizumab or cetuximab(Cmab)limited to the K-ras wild-type or panitumumab(Pmab)limited to the K-ras wild-type.At the present time, a common third-line chemotherapy is CPT-11 plus Cmab limited to the K-ras wild-type, or Cmab/Pmab.However, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.